12:00 AM
 | 
Apr 01, 2013
 |  BC Week In Review  |  Company News  |  Deals

Carna, RaQualia deal

RaQualia and Carna partnered to discover a compound targeting an undisclosed kinase. Carna will contribute its kinase drug...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >